1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Atelectasis Global Clinical Trials Review, H2, 2014

Atelectasis Global Clinical Trials Review, H2, 2014

  • December 2014
  • -
  • Global Data
  • -
  • 53 pages

Atelectasis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Atelectasis Global Clinical Trials Review, H2, 2014" provides data on the Atelectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atelectasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atelectasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Atelectasis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Atelectasis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Atelectasis to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Atelectasis to Respiratory Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Clinical Trial Overview of Top Institutes / Government 25
Dresden University of Technology 25
Clinical Trial Overview of Dresden University of Technology 25
Hospital Sirio-Libanes 26
Clinical Trial Overview of Hospital Sirio-Libanes 26
The University of Utah 27
Clinical Trial Overview of The University of Utah 27
Erasmus MC 28
Clinical Trial Overview of Erasmus MC 28
London Health Sciences Centre 29
Clinical Trial Overview of London Health Sciences Centre 29
Herlev Hospital 30
Clinical Trial Overview of Herlev Hospital 30
University of Oklahoma 31
Clinical Trial Overview of University of Oklahoma 31
University of Medicine and Dentistry New Jersey (Inactive) 32
Clinical Trial Overview of University of Medicine and Dentistry New Jersey (Inactive) 32
Massachusetts General Hospital 33
Clinical Trial Overview of Massachusetts General Hospital 33
Duke University 34
Clinical Trial Overview of Duke University 34
Five Key Clinical Profiles 35
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53

List of Tables
Atelectasis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Atelectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Atelectasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Atelectasis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Atelectasis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Atelectasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Atelectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Atelectasis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Atelectasis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Atelectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Atelectasis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Atelectasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Atelectasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Atelectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Atelectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014* 25
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sirio-Libanes, 2014* 26
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2014* 27
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 28
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2014* 29
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014* 30
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2014* 31
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey (Inactive), 2014* 32
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 33
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 34

List of Figures
Atelectasis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Atelectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Atelectasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Atelectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Atelectasis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Atelectasis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Atelectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Atelectasis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Atelectasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Atelectasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Atelectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Atelectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
GlobalData Methodology 52

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.